GE HealthCare and BARDA outlay $35m to expand AI ultrasound development contract
GE HealthCare and the US Biomedical Advanced Research and Development Authority (BARDA) have expanded an existing contract by $35m to …
Post
-
-
Medtronic’s Q3 2026 revenues reach $9bn on strong PFA demand
Medtronic has reported total revenue of $9bn in Q3 of fiscal year 2026 (FY26), led by the strongest growth the …
-
Levee secures over $12m to support Voro Urologic Scaffold PMA
Levee Medical has secured more than $12m in additional financing to support the premarket approval (PMA) process as the ARID …
-
Portal Diabetes’ insulin pump receives FDA breakthrough device designation
Portal Diabetes has received the US Food and Drug Administration (FDA) breakthrough device designation for its implantable insulin pump system, …
-
Danaher acquires Masimo for $9.9bn to bolster diagnostics business
Danaher Corporation has agreed to acquire Masimo in a cash deal worth $9.9bn in an effort to broaden its diagnostics …
-
Medica expands teleradiology network with Axon Diagnostics merger
Teleradiology provider Medica Group, has reached an agreement to merge Axon Diagnostics into its operations in a move anticipated to …
-
LEX Diagnostics secures FDA clearance for VELO PCR system
LEX Diagnostics has secured the US Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver …
-
VB Spine to acquire xvision Spine System from Augmedics
VB Spine has signed a definitive agreement to acquire Augmedics’ xvision Spine System to add augmented reality (AR) navigation to …
-
MHRA launches consultation on UK’s long-term approach to CE-marked medical devices
The Medicines and Healthcare products Regulatory Agency (MHRA) will evaluate the possibility of extending recognition of CE-marked medical devices beyond …
-
Median Technologies establishes distribution partnership with Tempus AI
Median Technologies has forged a partnership with Tempus AI, setting the former company up with its first US distribution agreement …
-
QuidelOrtho and Lifotronic agree on global immunoassay portfolio expansion
QuidelOrtho has signed a strategic supply agreement with Lifotronic Technology for expanding its global immunoassay portfolio, focusing on expediting access …
-
Medtronic secures FDA approval for Stealth AXiS spine robotics platform
Medtronic has received the US Food and Drug Administration (FDA) clearance for the Stealth AXiS spine surgery robotics platform. The system …
-
Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations
Dexcom has achieved revenues of $4.66bn in 2025 and beat analysts’ consensus for Q4 performance amid a strong demand for …
-
Novocure’s stock rises 37% on FDA clearance of pancreatic cancer treatment device
The US Food & Drug Administration (FDA) has cleared Novocure’s Optune Pax device for locally advanced pancreatic cancer treatment, representing …
-
OncoRes Medical raises funding to advance Elora clinical development
Australia-based OncoRes Medical has completed A$27m($19.1m) private funding round to support the clinical development and regulatory advancement of its quantitative …
